Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Other Operating Expenses (2022 - 2025)

Envoy Medical's Other Operating Expenses history spans 4 years, with the latest figure at $608000.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 8.96% year-over-year to $608000.0; the TTM value through Sep 2025 reached $1.8 million, down 29.23%, while the annual FY2023 figure was $2.5 million, 77.51% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $608000.0 at Envoy Medical, up from $595000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.9 million in Q3 2022 and bottomed at $478000.0 in Q1 2024.
  • The 4-year median for Other Operating Expenses is $601500.0 (2025), against an average of $805031.6.
  • The largest annual shift saw Other Operating Expenses tumbled 68.27% in 2023 before it skyrocketed 36.15% in 2024.
  • A 4-year view of Other Operating Expenses shows it stood at $1.0 million in 2022, then fell by 27.9% to $747000.0 in 2023, then dropped by 25.3% to $558000.0 in 2024, then rose by 8.96% to $608000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Other Operating Expenses are $608000.0 (Q3 2025), $595000.0 (Q2 2025), and $584000.0 (Q1 2025).